Structure (Otrexup 01)
Chemical structure diagram of the active ingredient in Otrexup, illustrating its molecular components and bonds.*
Otrexup Injection, Solution
Product Images NDC 54436-020
19 FDA label images from Antares Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Otrexup (NDC 54436-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Antares Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Antares Pharma Logo (Otrexup 02)
Antares Pharma Logo (Otrexup 03)
Ifu Figure A (Otrexup 04)
Instructional diagram for Otrexup, showing its parts including the cap marked 1, needle end, viewing window, label with 10 mg strength and methotrexate, and safety clip marked 2. The label and safety clip are shown separately, highlighting their locations on the prefilled autoinjector device by Antares Pharma, Inc.*
Ifu Figure B (Otrexup 05)
Instructional illustration showing hands preparing an Otrexup autoinjector pen with labeled steps, including removing a cap and positioning the device, as part of the injection process for the methotrexate solution.*
Ifu Figure C (Otrexup 06)
Otrexup autoinjector device showing a side view with a gray cap and a clear viewing window. The device includes a yellow component visible through the window, and part of a blue and white label is visible on the right. The label likely includes dosage or usage instructions. The product is labeled under Antares Pharma, Inc.*
Ifu Figure D (Otrexup 07)
An instructional illustration showing the recommended dosing areas for Otrexup injection on the human body. The highlighted areas include the thigh and abdomen, with arrows pointing to each labeled region indicating the appropriate sites for administering the medication.*
Ifu Figure E (Otrexup 08)
An instructional illustration showing hands operating an Otrexup prefilled autoinjector syringe. It depicts a step where the user holds the device and twists the yellow cap in a clockwise motion, demonstrating how to prepare the device for injection.*
Ifu Figure F (Otrexup 09)
Illustration showing hands holding an Otrexup prefilled syringe with instructions to twist and remove the yellow safety guard cap before use. The images demonstrate the correct way to detach the cap by twisting and pulling it off the syringe barrel.*
Ifu Figure G (Otrexup 10)
An instructional diagram showing the proper injection technique for Otrexup. It depicts a person holding the device at a 90-degree angle to the thigh with a downward motion and another image showing injection into the abdomen at a 90-degree angle with a horizontal motion. A timer icon indicates holding the device in place for 3 seconds during administration.*
Ifu Figure H (Otrexup 11)
Illustration showing the Otrexup autoinjector viewing window before and after dose delivery. The first view shows a clear yellow window indicating dose not delivered, and the second view shows the window half blocked with a red flag, indicating the full dose has been delivered.*
10 mg Label (Otrexup 13)
Otrexup 10 mg/0.4 mL subcutaneous injection label by Antares Pharma, Inc. The label includes instructions for a one-time use autoinjector with steps to twist cap, flip safety clip, and firmly push device for 3 seconds against thigh or abdomen. It specifies checking for color or particles and cautions if the window is blocked or tab across cap is broken. Storage instructions and lot/expiration placeholders are also present.*
12.5 mg Label (Otrexup 14)
Otrexup 12.5 mg/0.4 mL injection label for subcutaneous use, containing methotrexate. The label includes step-by-step instructions to remove the cap, flip the safety clip, and administer the injection with corresponding illustrations. It warns not to use if the tab across the cap is broken and specifies storage conditions. The label is from Antares Pharma, Inc., includes lot and expiration placeholders, and an NDC number 54436-012-02.*
15 mg Label (Otrexup 15)
Otrexup 15 mg/0.4 mL methotrexate injection label for subcutaneous use. The label includes step-by-step instructions for use: twist cap to remove, flip safety clip off, and push device firmly for 3 seconds. It contains warnings about needle end and broken tabs, dosage references, storage conditions, and placeholders for lot and expiration dates. Manufactured by Antares Pharma Inc.*
17.5 mg Label (Otrexup 16)
Otrexup 17.5 mg/0.4 mL methotrexate injection label for subcutaneous use by Antares Pharma, Inc. Features instructions for use in three steps with illustrations: removing the cap, flipping the safety dip off, and injecting at thigh or abdomen at 90 degrees. Includes warnings about not using if the tamper-evident tab across the cap is broken, dosage storage instructions, lot and expiration placeholders, and a barcode.*
20 mg Label (Otrexup 17)
Otrexup 20 mg/0.4 mL injection label by Antares Pharma, Inc. The label shows the proprietary name, methotrexate injection strength, and dosage form for subcutaneous use. It includes step-by-step usage instructions with illustrations for removing the twist cap, flipping the safety clip, and administering the injection at a 90-degree angle into the thigh or abdomen. Storage temperature guidelines, lot number, expiration date, and barcode are also visible on the label.*
22.5 mg Label (Otrexup 18)
Otrexup 22.5 mg/0.4 mL methotrexate injection label for subcutaneous use, manufactured by Antares Pharma, Inc. The label includes step-by-step illustrated instructions for use involving removing the twist cap, flipping the safety clip, and placing the needle flat against the thigh or abdomen to push the device firmly until fully depressed. Additional label details include a lot number and expiration date field, a warning not to use if the tab across cap is broken, and storage instructions.*
25 mg Label (Otrexup 19)
Otrexup (methotrexate) injection 25 mg/0.4 mL single-dose autoinjector label by Antares Pharma, Inc. It includes instructions for a one-time subcutaneous injection with steps to remove the twist cap, flip off the safety clip, and inject at a 90-degree angle. The label notes to check for color or particles and warns not to use if the tab across the cap is broken. Storage instructions and placeholders for lot and expiration dates are also shown.*
10 mg 4-pack Carton Label (Otrexup 21)
Otrexup 10 mg/0.4 mL packaging label for methotrexate injection for subcutaneous use only. The label includes dosage, usage instructions (use once weekly), and manufacturer information for Antares Pharma, Inc. The label also states the product contains 4 single-dose injections and includes inactive ingredients and storage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
